89 related articles for article (PubMed ID: 8974001)
1. The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
Oka M; Iizuka N; Yamamoto K; Gondo T; Abe T; Hazama S; Akitomi Y; Koishihara Y; Ohsugi Y; Ooba Y; Ishihara T; Suzuki T
J Interferon Cytokine Res; 1996 Dec; 16(12):1001-6. PubMed ID: 8974001
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
3. Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Koishihara Y
Jpn J Cancer Res; 1994 Sep; 85(9):958-65. PubMed ID: 7961126
[TBL] [Abstract][Full Text] [Related]
4. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
5. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
6. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
Keller ET; Ershler WB
J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study.
Taniguchi Y; Yorioka N; Oda H; Yamakido M
Nephron; 1996; 74(4):652-60. PubMed ID: 8956297
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myeloma.
Taetle R; Dos Santos B; Ohsugi Y; Koishihara Y; Yamada Y; Messner H; Dalton W
J Natl Cancer Inst; 1994 Mar; 86(6):450-5. PubMed ID: 8120920
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer.
Matsuzaki N; Neki R; Sawai K; Shimoya K; Okada T; Sakata M; Saji F; Koishihara Y; Ida N
J Clin Endocrinol Metab; 1995 Oct; 80(10):2912-7. PubMed ID: 7559874
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells.
Huang YW; Vitetta ES
Hybridoma; 1993 Oct; 12(5):621-30. PubMed ID: 8300137
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
[TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies.
Liautard J; Gaillard JP; Mani JC; Montero-Julian F; Duperray C; Lu ZY; Jourdan M; Klein B; Brailly H; Brochier J
Eur Cytokine Netw; 1994; 5(3):293-300. PubMed ID: 7524715
[TBL] [Abstract][Full Text] [Related]
14. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
15. Alternative assay procedures for cytokines and soluble receptors of the IL-6 family.
Oppmann B; Stoyan T; Fischer M; Voltz N; März P; Rose-John S
J Immunol Methods; 1996 Sep; 195(1-2):153-9. PubMed ID: 8814331
[TBL] [Abstract][Full Text] [Related]
16. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.
Wang LS; Chow KC; Wu CW
Br J Cancer; 1999 Jul; 80(10):1617-22. PubMed ID: 10408408
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-6 on the growth of human lung cancer cell line.
Fu J; Zheng J; Fang W; Wu B
Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin-6 behaves as an autocrine growth stimulator for a human lung giant cell carcinoma cell line].
Fu J; Zheng J; Fang W
Zhonghua Bing Li Xue Za Zhi; 1997 Feb; 26(1):5-7. PubMed ID: 10072840
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-6 functions as an autocrine growth stimulator for a human lung adenocarcinoma cell line PAa].
Fu J; Fang W; Zheng J
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):45-8. PubMed ID: 10743055
[TBL] [Abstract][Full Text] [Related]
20. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
